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Since  the establishment  of  in vitro  fertilization,  it became  evident  that  almost  half  of  the  couples  failed  to
achieve  fertilization  and  this  phenomenon  was  attributed  to a male  gamete  dysfunction.  The  adoption
of  assisted  fertilization  techniques  particularly  ICSI  has  been  able  to  alleviate  male  factor  infertility  by
granting  the consistent  ability  of  a  viable  spermatozoon  to activate  an  oocyte.  Single  sperm  injection,  by
pinpointing  the beginning  of  fertilization,  has  been  an  invaluable  tool  in  clarifying  the  different  aspects  of
early  fertilization  and  syngamy.  However,  even  with  ICSI  some  couples  fail  to  fertilize  due  to  ooplasmic
pen access under CC BY-NC-SA license.ailed fertilization
ocyte activation
CSI
LC
ssisted oocyte activation
dysmaturity  in relation  to the  achieved  nuclear  maturation  marked  by  the  extrusion  of  the  ﬁrst  polar
body.  More  uncommon  are  cases  where  the  spermatozoa  partially  or completely  lack  the  speciﬁc  oocyte
activating  factor.  In  this  work,  we review  the  most  relevant  aspects  of  fertilization  and  its  failure  through
assisted  reproductive  technologies.  Attempts  at diagnosing  and  treating  clinical  fertilization  failure  are
described.perm  cytosolic factor
alcium  inﬂux
. Fertilization
Fertilization is deﬁned as the process resulting from the fusion of
he two parental gametes, the oocyte and the spermatozoon. When
ammalian oocytes and spermatozoa meet in the oviduct, a series
f steps are set in motion that lead to fertilization and ultimately
o the development of a new individual. Fertilization induces a cas-
ade of critical events that result in the development of the zygote.
apacitated, free-swimming spermatozoa must initially recognize
nd bind following cumulus penetration to the zona pellucida of
he ovulated oocyte. The sperm cell must complete the acrosome
eaction that enables it to penetrate through the thickness of this
xtracellular coat, then bind to and fuse with the oocyte plasma
embrane to activate the ootid. These multiple steps have been
ostulated to involve receptor–ligand interactions, ion-channel
odulations, membrane fusions, and proteolysis [1–4].
During  fertilization, the mature oocyte is activated to engage
n embryo development. Oocyte activation involves a multitude of
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ommercial use, distribution, and reproduction in any medium, provided the
riginal author and source are credited.
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molecular changes depending upon the species. Generally, it is trig-
gered by the binding of the male gamete to the oolemma resulting
in intracellular Ca2+ [Ca2+]i release within the ooplasm during fer-
tilization [5]. The initial surge of free cytoplasmic Ca2+ starts from
the site of sperm penetration and expands as a wave through the
oocyte [6,7]. While one Ca2+ transient is registered in echinoderm,
ﬁsh, and frog oocytes [7], repetitive calcium oscillations that last
up to several hours are observed in mammals [8,9]. In mammals
the fertilization-dependent Ca2+ oscillations were considered to be
due to the release of a soluble cytosolic factor carried by the sperm
following fusion with oolemma [10,11]. A putative phospholipase
carried within the sperm head catalyzes the hydrolysis of PIP2
(phosphatidylinosital 4,5-bisphosphate) in the plasma membrane
releasing IP3 (inositol 1,4,5-triphosphate) and DAG (diacylglycerol).
IP3 binds to its receptor present on the endoplasmic reticulum
membrane, and elicits the ﬂux of Ca2+ into the cytoplasm [12]
needed to activate the oocyte [13].
2. Sperm-borne oocyte activating factor
To achieve fertilization, spermatozoa must trigger the needed
rise in ooplamic Ca2+ [14,15]. One of the most important compo-
nents of the male gamete is the soluble oocyte activating factor that
has been recognized in rabbit, hamster, boar, and human spermato-
zoa [16–18]. One form of this protein once termed oscillin localized
in the perinuclear theca of the sperm head that by the mobilization
of Ca2+ is capable of evoking oscillation patterns similar to that seen
Q.V. Neri et al. / Cell Calciu
Fig. 1. Spermatozoa injected into oocytes either as a head only, separated head
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snd  tail, and tail only. Regardless of the sperm component injection, fertilization
s  achieved, however, extremely low in the group that was inseminated with a
istinctly separated head and tail.
ollowing sperm extract exposure experiments [16]. The human
omologue of this hamster oscillin is glucosamine 6-phosphate
somerase (GPI, GenBank accession number D31766). However,
s we observed in our lab, the deployment of antibodies against
his compound did not interfere with the sperm extract’s ability
o activate oocytes, neither the injection of its recombinant form
as effective in inducing calcium oscillations [19]. This work as
upported by other investigators helped to indicate that this par-
icular molecule was not the speciﬁc sperm oocyte activating factor
19,20]. This knowledge helped refocus the quest toward the identi-
cation of the actual sperm soluble factor that generates intracellu-
ar IP3, an effort that led to the identiﬁcation of a phosphoinositide-
peciﬁc phospholipase C (PLC) [21,22]. Several PLC isoforms, ,
 and , present in the spermatozoa have been considered but
ere found to be absent from chromatographic fractions of sperm
xtracts that speciﬁcally cause Ca2+ oscillations [23,24].
The evidence of a novel PLC was ﬁrst obtained from the exam-
nation of short ESTs (expressed sequence tag) from mouse and
uman testis that enabled the isolation and characterization of a
ull length cDNA encoding a sperm protein that is now referred
o as PLC (zeta) [25]. PLC triggers Ca2+ oscillations in the mouse
ndistinguishable from those occurring following sperm penetra-
ion eliciting oocyte activation and early embryonic development
p to the blastocyst stage [26].
Interestingly in another study [27] that assessed the PLC as a
andidate sperm-borne activating factor detected the active PLC
soform in sperm fractions other than the perinuclear theca. It
ppears that PLC was incorporated as part of the acrosome dur-
ng both mouse and human spermiogenesis to gradually diminish
s sperm cells transitioned into elongated spermatids. In addition
uthors found that PLC was expressed and secreted by the epi-
idymal epithelial cells explaining its presence on the sperm head
urface. In fact, when IVF was carried out in bulls, PLC was  no
onger detectable following the occurrence of acrosome reaction
n the surface of the zona pellucida. This view may  appear in con-
radiction with the role of PLC as the activating factor because
urgically retrieved testicular spermatozoa in humans consistently
re capable of activating an oocyte.
In one of our earlier experiments, we tested the hypothesis that
perm cytosolic factor is a soluble compound deeply sealed within
he spermatozoon and may  not require spermatozoal integrity. We
evered sperm heads from their ﬂagellum and injected the severed
arts in several combinations: sperm heads, tails, or head + free tail
28]. Oocytes that survived the injection with isolated sperm heads
ielded 66.7% (44/66) fertilization rate, while oocytes injected with
nly sperm tails, two out 10 formed two pronuclei (possibly from
he anextrusion of the second polar body), and those injected with a
issected head along with its corresponding tail in 50.0% (12/24) of
he cases gave two pronuclei. It appears that the injection of isolated
perm head can still activate an oocyte (Fig. 1). This is consistentm 55 (2014) 24–37 25
with the hypothesis that PLC or the putative activating factor is
deeply embedded within the sperm head layers verisimilarly in the
perinuclear theca as previously described [29]. This work was in
agreement with studies using ICSI have shown that only the sperm
head is critical for egg activation and subsequent embryonic devel-
opment at least in the mouse [30–32]. We  closely demonstrated
that humans need the integrity of the spermatozoon to ordain the
normal chromosomal segregation [28,33,34].
3. Assisted fertilization
Infertility affects approximately 12–15% of couples in their
reproductive age [35] and about half of them, 1.2 million infertile
couples per year, beneﬁt from assisted reproductive technologies
(ART). Since its ﬁrst human birth in 1978, in vitro fertilization (IVF)
has been applied almost exclusively to alleviate tubal infertility, but
since the very beginning it became clear that the main challenge
of inseminating gametes in vitro was  to achieve a predictable fer-
tilization particularly when men  present with suboptimal semen
parameters [36].
In fact, if we exclude infertility indications such as unexplained
or concurrent causes, the main reasons for a couples’ inability to
procreate is almost equally allocated between the female and the
male partners. In most instances a man’s infertility is attributable
to the consistent phenomenon in the inability of spermatozoa to
successfully fertilize an oocyte. In the past, the reason was naively
attributed to the non-receptive characteristics of the zona pellucida
and therefore, a number of procedures were devised to over-
come this deﬁciency. These procedures are generally referred to as
techniques of assist fertilization or micromanipulation procedures.
The introduction of micromanipulation to handle human gametes
has allowed fertilization enhancements for severe oligozoospermia
(men with low sperm count), and even asthenozoospermia (poor
motility).
When sperm count, motility or morphology were inadequate,
various techniques were tested to bypass the zona pellucida. The
practical use of micromanipulation started in the mid-80 s with
zona drilling (ZD) and partial zona dissection (PZD). Since then,
this ﬁeld has undergone such a rapid evolution that these early
approaches have been abandoned in favor of intracytoplasmic
sperm injection (ICSI), leaving the use of PZD conﬁned to the
4–8 cell embryo stage (hatching) in an effort to promote implan-
tation. Zona drilling (ZD) ﬁrst reported by Gordon and Talansky
[37] involves the creation of a circumscribed opening in the zona
by acid Tyrode’s solution applied through a ﬁne glass micropipette.
Unfortunately, after insemination, more than one spermatozoon
frequently entered such perforated zonas resulting in polysper-
mic  fertilization. Moreover, the use of acidic medium to carry out
the drilling had a deleterious effect on the oocyte—an effect not
seen in cleavage stage embryos while using the ‘hatching’ proce-
dure. At the same time as ZD was being tested, mechanical cutting
of a hole in the zona was introduced, this was  originally devised
for nuclear manipulation of fertilized oocytes [38]. Alternative but
similar procedures were zona cracking in which the zona was
breached mechanically with two  ﬁne glass hooks controlled by a
micromanipulator [39], and zona softening performed by a brief
exposure to trypsin [40] or pronase. Partial zona dissection (PZD)
involved cutting of the zona with a glass needle before exposure
of the treated oocyte to spermatozoa [41]. For all these techniques,
spermatozoa had to be progressively motile and have the potential
to undergo acrosome reaction. PZD also carried a distinct risk of
injury to the oocytes from the need to produce an opening in the
zona of optimal size to allow spermatozoa to penetrate while at
the same time limiting this number to prevent polyspermy. Local-
ized laser photoablation was also adopted to introduce a gap of
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recise dimensions in the zona, and has resulted in a few healthy
ffspring [42,43]. However, not only did all these early procedures
ring modest improvement in fertilization rate, with PZD being
he most useful in that regard, but they were associated with an
nsustainable occurrence of polyspermy. Mechanical insertion of
permatozoa directly into the perivitelline space—subzonal sperm
njection (SUZI) [44]—was introduced as another way  to over-
ome inadequacies of sperm concentration and motility, and this
roved to be more effective than ZD or PZD, particularly following
rior induction of the acrosome reaction [45,46]. However, SUZI
lso remained limited due to its inability to overcome acrosomal
bnormalities or dysfunction of the sperm–oolemma fusion pro-
ess, resulting in mediocre fertilization rates as more severe forms
f male infertility were addressed.
The situation changed with the development of a procedure,
ntracytoplasmic sperm injection (ICSI), that entailed the insertion
f a spermatozoon into the ooplasm. This approach emerged as the
ne capable of providing the most reliable and consistent chances
f fertilization [47], because it bypasses all the initial steps of nat-
ral fertilization—penetration of the cumulus cells, binding to the
ona pellucida, and fusion with the oolemma. The technique was
ioneered in animals, initially by Hiramoto [48] in the sea urchin,
hen by Lin [49] in mammalian (mouse) oocytes. Later, Uehara and
anagimachi [50] observed relatively high rates of sperm nucleus
econdensation after microinjection of human or golden hamster
permatozoa into hamster oocytes, and at the same time ICSI was
sed to study the time determinants of male pronucleus forma-
ion [51,52]. This gamete manipulation approach carried the risk of
ocyte injury and lysis [53], and in early studies only about 30% of
njected mouse mature oocytes survived the procedure, even when
ne micropipettes were used under ideal conditions [54].
The ﬁrst live offspring were obtained in the rabbit following the
ransfer of sperm-injected oocytes into the oviduct of a pseudo-
regnant female [55], and soon after that a single ICSI live birth was
eported in the bovine [56]. Although applied to human gametes
ome years earlier [57] as a proof of concept, the ﬁrst human preg-
ancies with ICSI did not materialize until 1992 [47].
The ICSI technique is now widely used in assisted reproduc-
ion and has provided relevant information about the basic science
f fertilization. Mammalian eggs injected with whole mammalian
perm can exhibit normal events of egg activation, including Ca2+
elease [31,58–60], and can develop to term [30,32,47,61,62]. This
uggests that contact of sperm and egg plasma membranes is not a
ritical step for egg activation. Injecting sperm at various stages of
permiogenesis has demonstrated that elongating spermatids can
ctivate eggs, whereas round spermatids and secondary spermato-
ytes cannot [63–69]. Egg activation and subsequent development
ollowing ICSI are sperm-speciﬁc and cannot be substituted by
n artifactual introduction of Ca2+ into the egg from the outside
edium neither by an insertion of a glass pipette with or without
he injection of culture medium can sustain an intracellular release
f Ca2+ to activate the so injected oocytes [58–60,70–72].
More importantly, such micromanipulation approaches have
lso become a powerful tool for a more comprehensive under-
tanding of the basic elements of oocyte maturation, fertilization,
nd early development. Micromanipulation techniques now are an
mportant component of the process aimed at the diagnosis and
ometimes even the correction of genetic anomalies [73]. Similarly,
icromanipulation or microsurgery is employed toward optimiza-
ion of implantation rates in certain cases [74].
Because of the popularity of ICSI, trends toward the selec-
ion of the ideal spermatozoon to provide the most competent
amete capable of providing successful embryo development and
mplantation have materialized in “motile sperm organellar mor-
hology examination” (MSOME) to assess living male gamete
henotype sperm morphology under high magniﬁcation [75]. Withm 55 (2014) 24–37
this approach, screening is used to select a spermatozoon for ICSI
with an optimal shape. The procedure is christened “intracyto-
plasmic morphologically selected sperm injection” (IMSI), and its
use claimed to yield superior clinical outcomes than with conven-
tional ICSI [76]. The promised beneﬁcial impact of IMSI has been
described in a series of small studies where the clinical outcome
of patients treated by this procedure was  compared with that of
couples treated by conventional ICSI [77–80].
The high magniﬁcation morphological evaluation of viable
spermatozoa is carried out using an inverted microscope equipped
with interferential contrast Nomarski DIC optics. Maximum opti-
cal magniﬁcation (100× lens under oil immersion), magniﬁcation
selector (1.5×), and digital video-coupled magniﬁcation (44×) led
to a ﬁnal video monitor magniﬁcation of around 6600×. The crite-
ria for evaluating nuclei are smooth, symmetric, oval conﬁguration
and homogeneity of the sperm nuclear shape with ‘vacuoles’ not
exceeding more than 4% of the nuclear area surface [76]. The
role attributed to the sperm nuclear vacuole nor their position
within the sperm head is sill unclear. Only transmission electron
microscopy would clearly and accurately locate nuclear vacoules
[81].
The early ultrastructural studies of human sperm in the 1950s
and 60s, revealed that vacuoles in the sperm nucleus have been
seen in the large majority of human spermatozoa regardless of the
fertility of the donors. Vacuoles in human spermatozoa have in fact
been considered as a physiologic ﬁnding devoid of consequence
on fertility potential [82]. Because of this, the presence of sperm
nuclear surface vacuoles portend to sperm DNA defects with con-
sequent impaired embryo developmental competence need to be
revisited and analyzed. Another type of sperm head irregularity is a
surface “vacuole” or indentation, craters dent, or hollow observed
on the sperm coat. In such cases, during sperm morphogenesis, the
outer acrosomal membrane misforms and generates what appears
to be a vacuole [83]. These vacuole-like structures disappear as the
spermatozoon matures in the epididymis or at the time of the acro-
some reaction [84]. In other circumstances, however, they seem
to increase with temperature (37 ◦C) and incubation time (≥2 h)
[85], most probably due to the plication/vacuolization of the rostral
spermiolemma during capacitation. Interestingly, these vacuole-
like structures or craters appear in over 90% of spermatozoa from
fertile donors with normal semen parameters [86,87].
Higher magniﬁcation screening for sperm surface irregularities,
however, did not seem to beneﬁt the patients’ clinical outcome in
independent investigations [88]. This was true for patients with
compromised semen parameters and for those either undergo-
ing ﬁrst or repeated ART attempts. More detailed morphological
observations indicated that in human sperm heads visible irreg-
ularities or vacuoles are almost ubiquitous, and appear to be a
paraphysiologic ﬁnding. Analyses of spermatozoa from different
sources, ejaculated or surgically retrieved, also revealed the varying
presence and size of vacuoles that develop during the dynamic pro-
cesses of spermiogenesis and maturation. This surface irregularity
did not translate to a higher incidence of DNA fragmentation or
aneuploidy, nor to the ability of vacuolated spermatozoa to gener-
ate zygotes capable of developing to blastocysts.
4. How to diagnose fertilization failure
Despite the common successful utilization of IVF treatments
for infertile couples, cases of total fertilization failure continue
to persist. Their occurrence is emotionally devastating for cou-
ples, with signiﬁcant dissipation of logistic resources, and incurred
cost. Understanding the etiology of fertilization failure is of critical
importance to comfort patients during counseling and devising a
successful treatment.
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ICSI achieves a fertilization rate between 70 and 80% with ejac-
lated spermatozoa independently from the sperm’s functionality
s long as the male gamete is viable [89]. In some ICSI cases, with a
requency ranging from 3 to 5% [90], complete fertilization fail-
re occurs [91–96]. This complete fertilization failure can have
arious reasons [92–96] but most often occurs because of a nucleus-
ytoplasmic maturation asynchrony [96–100]. In a proportion of
hese cases, however, the inability of the male gamete to generate
onceptuses depends upon a defect in the presence or function of
he sperm cytosolic factor [101,102].
While ICSI has overcome many gametic defects, it does not
ompletely eliminate fertilization failure. The possible etiologies
nderlying total fertilization failure are complex [103] and may
elate to cycle-speciﬁc parameters, oocyte yield and quality, avail-
bility of motile spermatozoa and/or severity of sperm defects [90].
ale gamete abnormalities may  result in defective sperm DNA
econdensation, and/or aberrant pronuclear development, migra-
ion and apposition as well as abnormalities at mitosis [104,105].
ome ICSI inseminated oocytes fail to be activated [106] and this
ctivation failure has, under some circumstances, been successfully
vercome by exposure to calcium ionophore or electrical pulses to
anipulate intracellular calcium inﬂux [107–110].
Several early studies of gamete ultrastructure [94], staining of
NA [111] or whole chromosomes [112,113] have identiﬁed abnor-
al  chromatin patterns and/or chromosome numbers, of either
aternal or maternal origin, in non-fertilized oocytes. Recent stud-
es on ootid microtubules also revealed abnormal spindle and
nterphase microtubules, indicating that defects in oocyte cyto-
lasmic components may  also be a cause for failed fertilization
114,115].
One of the simpler approaches to test sperm-oocyte interac-
ion is the hamster ovum penetration test which is an apparently
traightforward sperm function assay based on the capacity of
uman spermatozoa to fuse with zona pellucida-free golden ham-
ter oocytes, leading to subsequent decondensation of the sperm
uclei [116]. This well recognized screening test presumably allows
he reproductive specialist to learn more about the ability of the
otential of a male gamete to fertilize an oocyte.
Sperm defects, however, are considered the leading cause of
ctivation failure, and given the universally relegated role of PLC
s the oocyte activating factor; it is highly plausible that defective
orms, or abnormal function, of PLC may  well be the underlying
ause of certain types of male-factor infertility and related oocyte
ctivation failure [101,117]. In fact, Heytens and colleagues [117]
bserved the ﬁrst genetic link between abnormal PLC and male
actor infertility by identifying the mutant PLC isoform in an
nfertile non-globozoospermic male. The identiﬁcation of speciﬁc
ocalization patterns of PLC in fertile males, and the precise
unctional relevance of PLC subcellular distribution, would pro-
ide a key benchmark to which suboptimal spermatozoa may  be
ompared and can be used as a diagnostic tool. Previous work
sing immunoﬂuorescent techniques has indicated that there
ppears to be a speciﬁc distribution of PLC in the sperm head,
ossibly in the perinuclear theca, that is consistent among fertile
permatozoa [29,117], and an abnormal localization pattern is
vident in spermatozoa that consistently failed to fertilize with ICSI
101,117–119]. This argues for a correlation between an abnormal
LC activity within the sperm head and its ability to activate the
ocyte at fertilization. In a quantitative analysis where real-time
CR was performed, the assessment of the relative expression of
LC may  provide a useful marker for the ability of the sperm to
nduce oocyte activation after ICSI more than chromatin maturity,
crosin activity or even the size of the acrosome [120]. In another
tudy that examined the levels of PLC protein present in the
perm of men  with normal oocyte activation versus those that
ailed to activate found that the oocyte activation deﬁcient groupm 55 (2014) 24–37 27
had signiﬁcantly lower levels of total PLC. However, signiﬁcant
amounts of variability was present in the sperm samples of the
same man  and between the control and oocyte activation deﬁcient
group indicating that this assay may  not be a clinically viable
prognostic indicator of oocyte activation capability [121].
To better understand the ability of the human spermatozoon to
interact with an oocyte without misuse of precious human mate-
rial, the use of heterologous ICSI insemination of rodent oocyte
has been proposed. While hamster oocytes are not suitable for
this purpose because they may  be easily activated by the injec-
tion procedure itself, instead mouse oocytes can be injected with
human sperm cells to test their aptitude to activate an oocyte [122].
To test this hypothesis, mouse oocytes were randomized to injec-
tion with motile human sperm, sham injection (medium only), and
heat-treated or salt-extracted spermatozoa. The motile spermato-
zoa generated an activation rate of 97% (102/105), while the sham
injected and heat-/salt-treated spermatozoa resulted in an activa-
tion rate of 14–20% [122]. Once the test oocyte is activated, the
human sperm nucleus decondenses forming a pronucleus allowing
the chromosome to replicate in a xenogenic environment. Fur-
thermore, a recent study [123] attempted to analyze the ability
of a mouse oocyte activation test (MOAT) to provide diagnostic
and prognostic information for patients suffering from fertiliza-
tion failure. The MOAT assay was  able to generate three groups
of patients depending on the ability of the spermatozoa to activate
the mouse oocyte, namely group 1 with ≤20%, group 2 21–84%,
and group 3 with ≥85%. The authors concluded that the patients
in group 1 are those that have sperm-related deﬁciency and the
likely cause of previous fertilization failure. However, for group 2,
the MOAT test is inconclusive where both sperm and oocyte deﬁ-
ciencies may  contribute to their previous fertilization failure, and
group 3, sperm-related deﬁciencies can certainly be refuted.
Among the spermiogenetic anomalies one of the most distinct
is represented by globozoospermia (also known as round-headed
sperm syndrome) which is a rare type of teratozoospermia account-
ing for <0.1% of male infertility [124]. Singh [125] described two
types of globozoospermia: type I with round-headed spermatozoa
lacking the acrosome and acrosomal enzymes and type II with
round-headed spermatozoa having remnants of the acrosome.
Most often these two  variants are represented within the same
individuals. The lack of an acrosome, whose production is a
postmeiotic event in spermatogenesis, and round sperm heads
are its main characteristics. An acrosomeless spermatozoon is
unable to penetrate the zona pellucida and therefore unable to
reach the oolemma of the oocyte [126,127]. However, even if these
spermatozoa are injected in the perivitelline space or within the
ooplasm most often fail to fertilize due to the dysruption of the
perinuclear theca and, therefore, lack of the sperm cytosolic factor
[128]. Even though round-headed spermatozoa can be seldom
present in infertile men, only in a few familial cases [129,130],
all spermatozoa will have the typical spheric head that require
diagnostic conﬁrmation through transmission electron microscopy
(TEM). In some rare cases men  with a well-deﬁned sperm abnor-
mality such as globozoospermia can be assessed for single gene
defects, such as SPATA16 (spermatogenesis associated protein 16)
[131] and PICK1 (protein interacting with c kinase 1) [132] which
are both presumably involved in the formation of the acrosome.
Single gene defects are commonly expected in patients with a
speciﬁc phenotype. However, the large majority of our patients
for male factor infertility suffer from poor semen parameters. For
these men, it is difﬁcult to predict whether a single gene defect is
exclusively responsible for their inability to procreate or is more
likely the result from an interaction of one or more genes that are
potentially reﬂecting environmental inﬂuence. In an earlier study
on a young couple with known globozoospermia, a multitude
of assays was performed to conﬁrm his globozoospermic status
2  Calciu
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133]. Patient had an unremarkable physical exam, 46XY kary-
type, negative Yq microdeletion, DNA damage of his unprocessed
emen was remarkably high at 80% and dropped when swim-up
as performed, with normal sperm aneuploidy rates. PLC was
ot detected by immunoﬂuoresnce or Western blotting. In this
ase, ICSI followed by oocyte activation with calcium ionophore
esulted in high rates of fertilization and an ongoing pregnancy
133]. In a case report, where the patient was diagnosed with
lobozoospermia as assessed by MSOME, somatic karyotype,
perm FISH, and genetic screening of SPATA16 and DPY19L2, the
se IMSI in this case generated 2 good quality embryos for transfer
hat resulted in a delivery of a healthy child [123]. Finally, in a case
eries of three patients with globozoospermia, MSOME  identiﬁed
ncreased levels of PLC relative to sperm from the sample that did
ot undergo MSOME. In fact, novel patterns of PLC in spermatozoa
xhibiting an acrosomal bud were observed. Each patient was
ble to obtain a pregnancy and go to term except for one who had
 miscarriage after a fresh and frozen embryo transfer [134]. In
ddition, a particular mouse strain, the wobbler, is a useful model
or globozoospermia and could also be used to study abnormalities
n PLC expression [135]. The wobbler mouse is characterized by
otor neuron disease where the males are infertile and whose
perm cells are round-headed lacking the acrosome. The presence
f PLC in the spermatozoa was lacking after immunohistochem-
stry but PLC protein expression was found in the testis. The
obbler sperm cells also had reduced fertilizing capacity that was
estored only after artiﬁcially activating the oocyte [135].
For patients that have experienced failed or low fertilization
ates with ICSI, it is important to have an assay to diagnose the
nderlying reason for the failure. The crucial question is how to
istinguish the activation deﬁciency due to a lack or depressed
ctivity of the sperm factor from the impaired ability of the oocyte
o respond to this factor. One way is to perform heterologous ICSI to
valuate the activation capacity of human spermatozoa by injection
nto mouse oocytes [128,136] as previously mentioned. However,
his is time consuming due to the need to stimulate and harvest
ouse oocytes and be impractical or unachievable in a hospital or
rivate setting. As we have tested in our practice, an alternative
ethod would be to search for the presence of the PLC within
he spermatozoa utilizing a polyclonal antibody [29,119]. Cases of
ailed fertilization where lack of the sperm cytosolic factor have
een clearly identiﬁed can be offered assisted oocyte activation.
The failure of fertilization due to sperm dysfunction attributable
o the PLC ineffectiveness can only be encountered in about 1%
f the men  affected with infertility. The incidence, however, of the
ocyte’s inability to be activated in our clinic is about 3%. Obviously,
ndependently from the PLC the female gamete has a responsibil-
ty in the process of oocyte activation. It is clear that an immature
oplasm is incapable of participating to the activation cascade as
re germinal vesicle (GV) or metaphase I (MI) stages. Since the
hift toward the routine use of recombinant medication associated
ith hypothalamic suppression with the GnRH antagonist, com-
lete failed fertilization has become more recurrent in patients with
istory of successful fertilization in stimulated cycles even in pres-
nce of adequate number of oocytes and apparently normal semen
pecimen [99].
The developmental competence that is acquired by the oocyte
s a result of the completion of meiosis to metaphase II (MII)
lays a critical role during fertilization and subsequent stages of
reimplantation embryonic development [137]. Several factors
ay  be related to an inability of the oocyte to activate. First, the
iming of maturational events appears to be tightly regulated
137–140] and the competence to undergo nuclear and cytoplas-
ic  maturation is acquired independently during folliculogenesis
141]. Oocytes are retrieved from varying follicle sizes may  carry
n immature cytoplasm despite the premature extrusion of them 55 (2014) 24–37
ﬁrst polar body. It has been postulated that such an asynchrony
between nuclear and cytoplasmic maturation may  be responsible
for the inability of the ooplasm to support decondensation of the
sperm nucleus [141,142]. In support of this idea, meiotic spindle
visualization reveals that these apparently mature oocytes (ﬁrst
polar body extruded) may  still be at telophase I or prometaphase
II [143–145] and even though deemed ready for ICSI, still contain
an immature cytoplasm incapable of participating to the oocyte
activation process.
While nuclear maturation is easily measured by the extrusion of
the ﬁrst polar body, cytoplasmic adequacy is not readily ascribable
and is highly dependent upon the integrity of oocyte-cumulus-
complex. We  believe that an asynchronous nuclear-cytoplasmic
maturation is responsible for the sporadic unexpected fertilization
failure. This is not an anomaly but is simply a transient stage that
can be easily corrected by lengthening the interaction between the
oocyte with its cumulus oophorus. To prove our point, we corre-
lated data between an unexpected failed fertilization cycle and a
successful one within the same patients. In a four-year time span,
we assessed ICSI patients who  had presented both cycles with and
without fertilization following ICSI including at least 3 MII  oocytes.
In this manner, the patient provided the study sample (failed fer-
tilization cycles) and its own  control (cycles with fertilization). We
also compared the study population to patients who achieved fertil-
ization in all oocytes injected considered as the gold standard [98].
A total of 8224 ICSI cases were reviewed, and of these, 6154
(74.8%) couples used their own  gametes. We  identiﬁed 183 (3.0%)
couples that were characterized by complete failed fertilization
and only 37 (0.6%) fulﬁlled the inclusion criteria. No differences
were observed between the cycles that had successful fertilization
and those that did not: maternal age, BMI, days of stimulation, or
lead follicle size. While the hCG to oocyte retrieval interval (hCG-
OPU) was similar between the study and control group, the hCG
to decoronization (hCG-DEC) and hCG to ICSI intervals revealed
a signiﬁcantly shorter length in the failed fertilization cycles
( = −39 min  and  = −36 min, respectively; P = 0.01) (Fig. 2). The
increasing length in hCG → DEC in the study group versus its own
control as well as the standard is depicted in Fig. 3 ( = −31 min,
 = −59 min, and  = −65 min, respectively; P < 0.01).
Here, we  infer that cumulus cells facilitate signaling pathways
instrumental in the acquisition of ooplasmic competence. This con-
clusion ﬁnds support in in vitro maturation studies, which indicate
that the integrity of the cumulus–oocyte-complex plays a pivotal
role in the expeditious completion of cytoplasmic maturation [146].
When all the different attempts to understand the reason for the
failure of fertilization, and after dedicated counseling and related
consent is obtained, the ultimate way to rule out gamete dysfunc-
tion is to inseminate the patient’s oocytes with anonymous donor
sperm. On the other hand, in resilient cases that fail to fertilize
even with donor spermatozoa, the utilization of anonymous donor
oocytes may  be able to pinpoint the gamete responsible for the
inability to generate a zygote.
5. Treatment Options
With the advent of standard in vitro fertilization procedures
it became evident that infertile couples whose male partner dis-
played suboptimal semen parameters often fail to yield zygotes.
Successful fertilization in vitro is usually affected by the number
of motile spermatozoa available as well as their morphology. In
some cases, the chances of fertilization can be enhanced by simply
decreasing the medium volume and enhancing spatial interactions
between the gametes such as in the microdrops insemination tech-
nique. This approach was  capable of raising chances of fertilization
to over 40% and providing a clinical pregnancy rate of 24% [147].
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Fig. 2. ICSI cycles including study group (blue) and paired control (red) as well as the gold standard (yellow). The time interval from hCG administration to oocyte pick up
(OPU)  was  shorter than the gold standard (P < 0.001) (a). The time interval from hCG administration to decoronization (DEC) was also shorter in the study group in comparison
to  their own  control (P < 0.01) and standard (P < 0.001) (b). Finally, a similar pattern in observed in the hCG administration to ICSI injection between the study being the
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fhortest in comparison to their own  control (P < 0.01) and standard (P < 0.001) (c). (F
he  web version of the article.)
ith the adoption of assisted fertilization techniques based on
ypassing the zona pellucida, such as zona drilling, partial zona
issection, and subzonal injection, there was an expectation for
 superior outcome. However, these procedures still needed nor-
al  functioning and capacitated spermatozoa for sperm–oolemma
ig. 3. Time interval between hCG administration and cumulus removal. An example of
o  removal of the cumulus (DEC, decoronization). The patients in the study group (blue) 
ertilization (red) and the gold standard (yellow). (For interpretation of the references to erpretation of the references to color in this ﬁgure legend, the reader is referred to
fusion to occur, thereby resulting in unacceptably poor fertilization
rates [148].
Assisted fertilization by ICSI has brought down the ratio of the
two parental gametes to 1:1, whereas an individual spermato-
zoon is paired to an oocyte, paving the way to important clues
 patients (n = 20) plotted according to the length of time from hCG administration
had the shortest time interval (hCG → DEC) in comparison to their own  cycle with
color in this ﬁgure legend, the reader is referred to the web version of the article.)
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egarding the intimate interaction between the two  gametes. ICSI
as been comparably successful whether the sperm sample is
resh or frozen, with suboptimal semen parameters and other con-
ounding factors such as the presence of anti-sperm antibodies. All
hese aspects of male infertility appeared insurmountable by other
ssisted fertilization techniques but appear to have a negligible
mpact on ICSI outcome [149,150]. Interestingly, ICSI performance
s not related to whether spermatozoa were collected from ejac-
late or, were retrieved surgically, from the epididymis or testis
151,152]. Moreover, ICSI’s dependability has broadened its ini-
ial use from a technique capable of overriding the dysfunction of
permatozoa to one that may  partly overcome issues related to the
ocyte [153]. Even though ICSI has the ability to overcome many
bstacles, we can only stress that ICSI does not guarantee success-
ul fertilization to every patient, and complete fertilization failure
an still occur. Such failures as previously have been reported to
e between 1% [90] and 3% [154] and may  be explained by dif-
erent factors related to oocytes and/or spermatozoa [153]. The
erminology “failed fertilization” typically refers to failure of all
he available mature MII  oocytes to fertilize. The principal cause
f failed fertilization has been attributed to an oocyte activation
isruption [94] whether related to female or male gamete dysfunc-
ion.
While recent studies aim at unveiling the intricate steps of
he oocyte activation that trigger intracellular Ca2+ oscillations in
he typical manner, in the clinical setting we currently observe
omplete and recurrent fertilization failure by enhancing the per-
eability of the oolemma and by modulating extracellular content
o favor calcium inﬂux.
Different protocols for assisted oocyte activation (AOA)
ave been established and are commonly divided into three
ubtypes—mechanical, electrical, and chemical stimuli—that elicit
ne or several calcium transients. During mechanical activation of
ocytes, oolemmas are pierced using a microneedle to favor a cal-
ium inﬂux, and after a short period, ICSI is performed [60]. Another
ethod for mechanical oocyte activation is the direct microinjec-
ion of calcium into an oocyte to increase intracellular calcium
155]. Electrical stimulation is another way to activate oocytes
y allowing calcium inﬂux through the formation of pores in the
lasma membrane. The efﬁciency of this procedure depends on
ore size, ionic content of the surrounding medium, and cell type.
lectrical oocyte activation has been successfully used on bovine
nd human oocytes [110,156]. While it appears predictable and
ot noxious to the oocytes in terms of overall voltage and length
f time exposure, it has been shown to induce reactive oxygen
pecies [157]. Chemical compounds can also induce a calcium rise
hat initiates oocyte activation. It has been described with the
se of compounds such as ethanol, calcium ionophore A213187,
onomycin, puromycin, strontium chloride, phorbol ester, and
himerosal [158]. These chemicals facilitate the inﬂux of extracel-
ular calcium ions into the oocyte due to the pores generated. Some
f these compounds may  induce a single or insufﬁcient calcium
ise in the oocyte while others may  induce multiple and unpre-
ictable calcium spikes [159]. However, human oocytes do not
lways respond to common mammalian oocyte activators such as
ost of the aforementioned agents. To mimic  the natural pattern
f calcium rise after sperm penetration or to optimize the rate of
uman oocyte activation, these agents are sometimes applied in
ombination [160].
A series of studies and case reports have focused on the use
f assisted oocyte activation with a variety of agents [90] provid-
ng more consistent fertilization with term pregnancies. However,
ot all assisted oocyte activation studies have a successful out-
ome due to the small or no improvement in fertilization [161]
r not being able to support a successful pregnancy. One of the
arliest studies was a case report on ICSI couples characterizedFig. 4. Transmission electron microscopy (TEM) of spermatozoa was performed to
diagnose globozoospermia in a man.
by poor fertilization, where the use of calcium ionophore post-
injection lead to reasonable zygote formation [162]. Another cohort
of 56 patients with a history of inconsistent fertilization due to
severe sperm head abnormalities used ionomycin to enhance fer-
tilization but failed to generate good quality embryos [163]. In
another study where globozoospermic (n = 10) and oligo-astheno-
terato-zoospermic (n = 20) men  were treated by injecting CaCl2
concurrently with ICSI followed by sequential exposure of cal-
cium ionophore not only gained superior fertilization but provided
clinical pregnancies and deliveries of healthy neonates [155]. In a
larger group of patients with severe teratozoospermia (n = 87), cou-
ples without or with extremely low fertilization beneﬁtted from
10 m ionomycin which in turn positively affected implantation
and pregnancy rates [164]. In another center, reproductive biol-
ogists utilized strontium chloride to help couples with previous
failed fertilization (n = 9). The authors were able to achieve high
fertilization rates with good quality embryos for transfer and deliv-
ery of healthy babies [164]. In the largest case series (n = 246), this
team allocated half of the sibling oocytes to electrical oocyte activa-
tion and the other half to no treatment. They were able to increase
fertilization in the electrical oocyte activation group to 68% versus
60% in the control (P < 0.001). However, this enhancement did not
translate in a higher pregnancy rate [165].
From September 1993 to June 2010, we  have treated 11,390
couples by ICSI, representing 2.0% of the cycles with absolute fer-
tilization failure. In 59 couples that had recurrent fertilization
failure because of the lack of oocyte activating factor, only nine
couples consented to undergo gamete pre-treatment. The cou-
ples (female age 37.4 ± 4 yr) had an average of 2.3 cycles with no
fertilization with an average of 10.8 oocytes injected. They were
subsequently treated in 18 cycles that produced a comparable num-
ber of oocytes (11.2). In one cycle, only a single MI  oocyte was
retrieved that did not mature. One man  had a familial case of
globozoospermia conﬁrmed by TEM (Fig. 4). The semen specimens
utilized for their gamete-pretreatment had an average concentra-
tion of 58.6 ± 40 × 106 ml–1 with a mild impairment in motility of
21.6 ± 11%, and morphology of 1.8 ± 1%.
In all instances, the inability of the spermatozoa to induce oocyte
activation was tested by injecting them into mouse oocytes [136].
In addition, prior to their AOA-ICSI treatment, we evaluated their
spermatozoa for the presence of PLC by polyclonal antibody. PLC
in these men  was signiﬁcantly lower ranging from 0 to no more than
14.4% of positivity in over 500 sperm cells/patient in comparison
to 37–81% spermatozoa of fertile individuals (P = 0.0001) (Fig. 5).
To help facilitate the nuclear decondensation process without
removing the sperm membrane and associated proteins, such as
Q.V. Neri et al. / Cell Calciu
Fig. 5. Phospholipase C zeta (PLC) staining of spermatozoa where the central cell
within the dotted box is positive (green ﬂuorescence). The solid box indicated a
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LC, we utilized a bacterial toxin–streptolysin O (SLO) [136,166].
teptolysin O is a streptococcal secretory protein that permeabi-
izes cells by interacting with cholesterol in the plasmamembrane
167], aggregating within the lipid bilayer, and forming stable
ores of 30 nm size [168]. The pores give continuous access to
he intracellular milieu without stripping off the membrane, thus
aintaining the integrity of the spermatozoon as well as its motility
nd the needed signal transduction pathways that maybe ini-
iated through the constituents of the membrane such as the
ell-surface receptors and sperm soluble factors. Spermatozoa were
xposed to SLO (30 min) prior to ICSI to assist in sperm membrane
ermeabilization [169]. Following sperm injection, oocytes were
equentially treated with Ca2+ ionophore [119,136,155].
We were able to obtain a fertilization rate of 52.9% (41/79) with a
leavage rate of 87.7% with the mean number of blastomeres at day
 of embryo development being 7.2 ± 1 and a mean fragmentation
ate of 8.4% ± 4. An average of 1.7 conceptuses were successfully
eplaced in all AOA cycles. A total 7 (38.9%) women  had positive
hCG of which 3 (16.7%) progressed to clinical pregnancies and
ne couple delivered a healthy baby boy [166].
A multitude of studies have been carried out in mammals that
dentiﬁed the need for a so called “sperm factor” to trigger oocyte
ctivation and subsequent embryo development. Biochemical
haracterization of the sperm extracts revealed that the active key
omponent of the sperm factor is PLC [170] that has the intrinsic
bility to cause Ca2+ oscillations in the oocyte while other isoforms
o not. With the prevalence of oocyte activation deﬁciency, many
tudies have used chemical and electrical activation but with
nconsistent results [158]. This brought forth the idea that a
hysiologic approach would be to utilize PLC in some speciﬁc
orm. Several studies proposed to inject recombinant PLC RNA
nd protein into mouse oocytes and this induced Ca2+ oscillations
imilar to those observed at fertilization and triggered embryo
evelopment to the blastocyst stage [25,26,171]. Interestingly,
uman sperm exhibiting deﬁcient PLC expression was  rescued by
o-injection of mouse PLC mRNA into mouse oocytes [117,118].
nother study showed that the microinjection of oocyte activation
eﬁcient spermatozoa along with exposure to calcium ionophore
enerated live offspring [133]. Furthermore, microinjection of
ocytes, that failed to fertilize with ICSI, with PLC cRNA resulted
n the appearance of prolonged Ca2+ oscillations where each
ransient Ca2+ wave was accompanied by a small coordinatedm 55 (2014) 24–37 31
cytoplasmic movement [172]. These studies further solidiﬁed
the idea that PLC is a great candidate as a clinical therapeutic
solution that could avoid potentially deleterious effects associated
with AOA, which use the non-physiological stimuli. However, the
therapeutic utilization of PLC cRNA is not likely viable since the
uncontrollable transcription of PLC may  be detrimental to normal
pre-implantation development through gene expression irregu-
larities, with eventual developmental defects observed in some
embryos [173]. In addition, injected PLC RNA could potentially, by
reverse transcription into cDNA, be incorporated into the genome
[174]. Therefore, an active and puriﬁed human recombinant PLC
protein would be the ideal alternative for therapeutic application,
as it would function in a more physiologic fashion [175].
Despite the widely conserved role of the phosphoinositide path-
way and Ca2+ release in oocyte activation, the mechanism(s) by
which sperm induces IP3 production remained unclear for quite
some time. In mammals, growing experimental evidence supports
the notion that, following fusion of the gametes, a factor from
the spermatozoon is responsible for inducing Ca2+ oscillations
and inducing IP3 production [176]. Initial evidence stemmed from
injection of cytosolic sperm extracts into oocytes that reproduced
the Ca2+ responses associated with fertilization regardless of the
oocytes’ species of origin [18,72]. So in our laboratory, we puriﬁed
the sperm cytosolic factor (SCF) from human spermatozoa of fer-
tile donors by freeze–thawing and sonication. Human oocytes that
were not activated with round spermatids were reinjected with the
frozen-thawed sperm fraction with a ﬁnal concentration of at least
one sperm equivalent/pl allowing the delivery of 5 pl volume of
SCF into each oocyte. Sham injections with culture medium did not
induce long-lasting Ca2+ rises. The injection of 5 pl of SCF elicited
persistent Ca2+ oscillations [72,177]. Pronucleus formation in 90%
of the human oocytes that survived the procedure (19/21) sug-
gested that the fertilization failure was due to lack of the oocyte
activator within the injected male gamete. Cytogenetic analysis
of the resulting zygotes conﬁrmed the involvement of the male
genome. The main limitation of this approach is that the SCF is not
patient speciﬁc and was derived from pooled specimens.
Considering that during the process of oocyte activation there
is always the need to ﬁrst produce IP3 to initialize the endogenous
calcium release and sustain subsequent oscillation, we  thought to
directly inject IP3 into the mouse oocytes [178]. In order to main-
tain the exact frequency of the release, we used caged-IP3 that was
injected into mouse oocytes to test the feasibility of highjacking the
oocyte calcium release cascade and triggering calcium oscillation
in a comparable manner to what occurs during normal fertiliza-
tion. In response to the uncaging of IP3 by exposure to UV light, a
rise in cytosolic calcium generating an oscillation every 30 min  that
was comparable to the calcium inﬂux occurring during physiologic
fertilization (Fig. 6) (Lee and Machaca, unpublished data).
With these encouraging ﬁndings, we then attempted to simulate
the physiological calcium cascade in humans. IP3 (d-myo-inositol
1,4,5-triposphate potassium salt, Invitrogen) was  directly injected
into 15 donated human oocytes (IRB 9801003210) matured in vitro.
The IP3 concentrations injected ranged from 1 M, 5 M,  10 M,
and 100 M but unfortunately, none of the oocytes showed any
sign of activation. The concentration of 1–10 M IP3 was  probably
too low allowing immediate metabolization by the oocyte. While
cells injected with 100 M became vacuolated possibly due to
non-speciﬁc activation of the calcium cascade unrelated to oocyte
activation generally seen during fertilization [136].
An important aspect to identify spermatozoa capable of achiev-
ing fertilization is their viability. This, however, cannot be directly
assessed on stage while performing ICSI and is conventionally
extrapolated by a spermatozoon’s kinetic characteristics. In fact,
we know that samples from severe asthenospermic (extremely low
motility) men  can be successfully treated by ICSI but conditio sine
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Fig. 6. Metaphase II oocytes treated with caged IP3 (a). The uncaging of IP3 through UV exposure enhanced calcium in-ﬂux in one oocyte (red/pink) (b). The side graph
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ua non to achieve fertilization is sperm viability as detected by its
otility.
Since early attempts of intra-ooplasmic injection, it was
eported that completely immotile spermatozoa, referred to at the
ime as “dead” [179], would still actually achieve fertilization in
nimals. However, early experimentations of actual injection of
mmotile human spermatozoa into an oocyte, failed to achieve
ertilization and to distinguish the native immotile possibly non-
iable from the recently immotile obviously which brought to
he introduction of sperm immobilization prior to ICSI (Palermo
t al. 1999; [93]) aimed at answering the question of whether
n immotile, but viable spermatozoon is capable of activating an
ocyte. To prove this a progressively motile sperm cell was slashed
n its ﬂagellum with a glass pipette. The modiﬁcation did indeed
ramatically increase fertilization (Palermo, personal communica-
ion).
As a proof of this concept, we propose the use of ATP/MgSO4
olution to stimulate the kinetic machinery to distinguish
permatozoa that possibly retain their ability to fertilize an oocyte.
pon exposure to ATP, 64.6% (296/458) of the spermatozoa eval-
ated were actually revived as detected by ﬂagellar twitching. To
onﬁrm whether these spermatozoa can still activate an oocyte,
e carried out a PLC assessment and evidenced that the putative
oluble sperm cytosolic factor was maintained in the perinu-
lear theca. We  plan to use this treatment on surgically retrieved
permatozoa and for those recovered after cryopreservation, where
bsence of motility is often observed and do not respond to motility
nhancers.
We tested this procedure on a frozen-thawed epididymal
pecimen that although had a concentration of 34.0 × 106ml−1,
permatozoa were all immotile and did not respond to motility
nhancers with a viability of 33.2%. ATP incubation was able to
licit kinetic motion in 59.8% (79/132) of the exposed sperm cells
180]. Comforted by this outcome, in a one couple where the male(c). (For interpretation of the references to color in this ﬁgure legend, the reader is
partner was azoospermic post-chemotherapy, the only available
specimen was  accidentally thawed during intercontinental trans-
port with obvious loss of motility, the immotile spermatozoa were
unable to fertilize once injected into ﬁve oocytes. In a subsequent
cycle, following exposure to ATP solution, we were able to “resus-
citate” enough spermatozoa to inject 16 oocytes that after calcium
ionophore yielded 37.5% pronuclear formation. Unfortunately,
even though two  conceptuses were placed in the female partner
no implantation occurred. In a later attempt, only three oocytes
fertilized but also in this implantation was  also unsuccessful.
To treat the fertilization failure, due to nucleus-cytoplasmic
asynchrony we identiﬁed two patients with apparently normal
gametes and recurrent fertilization failure. In their subsequent ICSI
cycle we  changed their hormonal stimulation proﬁle aiming at
reducing the number of follicles to enhance the estrogen content
at the same time hoping to increase the number of MII  oocytes
at retrieval. To allow enough time for the ooplasm to mature, we
lengthened the post-retrieval in vitro incubation time by leaving the
oocyte–cumulus-complexes undisturbed. We  accomplished that
by making sure that the patients were the ﬁrst to have their oocytes
retrieved and the last ones to have their cumulus cells removed.
This facilitated the cumulus-enhanced post-retrieval in vitro mat-
uration of the ooplasm. The fertilization rate was 4/4 (100%) and
6/10 (60%) that resulted in two viable intrauterine gestations.
6. Safety and conclusions
The introduction of intracytoplasmic injection of a sperma-
tozoon has alleviated the important aspect of human infertility
related to the male partner. This procedure has clariﬁed the dif-
ferent steps that result in the development of a new conceptus
but has also allowed to pinpoint some dysfunctional aspects of
the male gamete such as its inability to activate the oocyte. At
the present time, cases with persistent failed fertilization can only
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e solved by using assisted oocyte activation and the most widely
dopted agents for human oocytes include Ca2+-ionophore and ion-
mycin, at times strontium chloride, or electrical stimuli [155].
owever, these methods represent indiscriminate attempts to acti-
ate the oocyte by ﬂooding its ooplasm with calcium ions that do
ot follow the physiological cascade [117]. This practice fuels con-
erns as to how such chemicals may  affect embryo viability and
uture offspring well-being due to potential cytotoxic, mutagenic
nd teratogenic effects they may  have [2,158].
It has been postulated that inappropriate or insufﬁcient Ca2+
scillations may  have long term consequences on embryo devel-
pment and offspring well-being [181]. The literature shows that
uccessful pregnancies have been achieved with the use of AOA
n patients that had a history of failed fertilization with ICSI
107–110,155,164,182–188]. Several reports on the well-being of
hildren born after ICSI with AOA have provided reassuring insights
esulting with neonatal outcome within normal limits in regard to
irth weight, gestational age, neonatal malformations, and occur-
ence of perinatal mortality [110,155,185]. In a cohort of 22 children
orn after AOA, regardless of the chemical used – SrCl2 or A23187 –
rom birth to 4 years of age the activation process did not adversely
ffect height, weight, rate of malformation, and early development
f these children [189]. In a larger cohort of 39 children evaluated
t birth, it was  found that birth weight and gestational age were
ot affected by the use of AOA. Some of the children were then
eevaluated at the age of 3 and found that their IQ, motor skills,
nd behavioral proﬁle were within normal limits [190].
There is now substantial evidence indicating that oocyte acti-
ation in mammals is triggered by the sperm speciﬁc PLC
25,117,118,191]. In fact, there is a growing interest in the possibil-
ty that defects in PLC function are responsible for certain types of
ale infertility. It has been proposed that the reduced levels or the
xistence of an inactive form of the oocyte activating factor in the
perm cell account for the rare cases of failed fertilization after ICSI
188]. The ﬁrst observation was in the level and localization pattern
f PLC in infertile men  and healthy donors, even though vari-
bility in immunoﬂuorescence was observed [29]. Subsequently, a
eport came out with the ﬁrst genetic link between abnormal PLC
xpression and male factor infertility with the identiﬁcation of the
utant PLC isoform [117]. A second PLC expression mutation was
etected on the same patient manifesting as a substitution of histi-
ine for leucine (H233L) within the X catalytic domain which was
aternally inherited and was only treatable with the injection of
he PLCH233L cRNA [191].
It appears that screening for PLC content allows the identiﬁ-
ation of couples that may  beneﬁt from assisted oocyte activation
nd provides them with a chance to conceive their own biologi-
al child. All the men  included in our study had a lower content
f PLC in the majority of their spermatozoa. This was more evi-
ent in the spermatozoa from globozoospermic men  where the
ocyte activating capacity is completely missing as shown by the
bsolute inability to yield fertilization with ICSI. Now our cur-
ent predicament is that the large majority of our female patients
eeding assisted oocyte activation are over 35 years old, thus
ncreasing their chance of generating aneuploid oocytes, and as
uch introducing a possible confounding factor into the process of
mbryo developmental competence following AOA.
Recurrent fertilization failure after ICSI can be successfully over-
ome by AOA treatment following sperm injection just triggering
ntracellular calcium oscillation in a calcium rich environment. The
actitious exogenous calcium inﬂux does not exclude the possibil-
ty that subtle effect on embryo development and gene expression
egulation may  occur in oocytes activated by ionophore treatment
181] and to examine this possibility, further studies will be needed.
 more physiological intervention would be the injection PLC RNA
r protein [175,192,193] at the time of ICSI, and may  representm 55 (2014) 24–37 33
an important and novel physiological therapeutic strategy in these
cases of failed fertilization. However, derivation of human recom-
binant PLC has proven to be problematic due to the need to use
bacterial cell line, whole lysates, and at times the puriﬁed proteins
are inactive [194].
At present, the current protocol to obviate human oocyte acti-
vation failure has been the indiscriminate ﬂooding of the ooplasm
with exogenous calcium. Although these efforts at correction
appear safe there is a strong desire to devise more physiological
methods to override the spermatozoal dysfunction to activate the
oocyte for fertilization. Regardless of whether there is one or mul-
tiple proteins involved with oocyte activation, further work should
be carried out since fertilization failure carries a high emotional
and ﬁnancial toll and ﬁnding new treatments would help alleviate
afﬂiction and distress to infertile couples.
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